阿巴梅塔皮尔:对一个古老问题的新解决方案
1Department of Dermatology Venereology and Leprosy, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
International journal of trichology
|May 1, 2025
概括
2020年7月批准的新型金属蛋白酶抑制剂阿巴梅塔皮尔 (Abametapir) 提供了一种独特的双作用局部治疗,通过向成年寄生虫和它们的卵. 这种新型的杀剂在治疗头感染方面提供了潜在的进步.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 寄生虫学的寄生虫学
背景情况:
- 头感染 (脚病) 是一个常见的公共卫生问题.
- 现有的治疗方法往往面临着对蛋的耐药性和有效性的挑战.
- 金属蛋白酶在蛋的化过程中起着至关重要的作用.
研究的目的:
- 推出Abametapir,一个新批准的局部脚杀药.
- 讨论阿巴梅塔皮尔的新作用机制.
- 审查阿巴梅塔皮尔的开发,使用和不良影响.
主要方法:
- 对阿巴梅塔皮尔的发展史的回顾.
- 分析其作为金属蛋白酶抑制剂的作用机制.
- 关于其有效性和安全性的临床数据摘要.
主要成果:
- 阿巴梅塔皮尔于2020年7月获得FDA批准,用于局部使用.
- 它的独特目标是金属蛋白酶,这对于蛋化和成年的生存至关重要.
- 该药物为治疗脚病提供了一个新的治疗选择.
结论:
- 阿巴梅塔皮尔代表了当地的小杀药的重大进步.
- 它的双重作用机制为对抗子和防止再次感染提供了一种新的方法.
- 皮肤科医生应该意识到他们的病人这种新的治疗选择.
更多相关视频
06:44Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
383
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.7K
相关概念视频
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
241
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
241
